FREDUN Q2 FY27 ; STANDALONE NET PROFIT UP 93.44% AT ₹18.83 CR (YOY), UP 43.09% (QOQ)

TOTAL INCOME UP 84.21% AT ₹267.64 CR (YOY), UP 17.26% (QOQ) EBITDA UP 90.74% AT ₹42.60 CR (YOY), UP 29.96% (QOQ) MARGINS AT 15.92% VS 15.37% (YOY), 14.36% (QOQ)

Fredun Pharmaceuticals Ltd

Open attachment

← Back to feed